Huperzine a improves chronic inflammation and cognitive decline in rats with cerebral hypoperfusion
- 30 September 2009
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 88 (4) , 807-815
Abstract
Chronic cerebral hypoperfusion has been suggested to contribute to the progression of dementia. Inflammation and white matter lesion (WML) are involved in the pathologic process. This study investigated whether huperzine A, a natural acetylcholinesterase (AChE) inhibitor, has beneficial effects on long‐lasting inflammation as well as cognitive impairment in a rat model of cerebral hypoperfusion and how it plays these roles. Chronic cerebral hypoperfusion was induced by occlusion of bilateral common carotid arteries (two‐vessel occlusion; 2VO). Huperzine A was initially given 150 min after 2VO and daily for 3, 7, 14, and 28 days. Learning and memory dysfunction as tested by Morris water maze performance was observed in 2VO‐operated rats and was significantly improved by huperzine A treatment. WML and activation staining of immune cells were evaluated by Klüver‐Barrera (KB) and immunohistochemistry, respectively. Myelin damage and increased immunostains were found in optic tract at all indicated days. Huperzine A treatment significantly ameliorated all these phenomena. Moreover, huperzine A also suppressed overexpression of the inflammatory factor tumor necrosis factor‐α (TNF‐α) and overphosphorylation of JNK and p38 mitogen‐activated protein kinases (MAPKs) in a cell model of chronic hypoxia. Preincubation with mecamylamine (MEC), a nicotinic acetylcholine receptor (nAChR) antagonist, for 30 min before hypoxia notably reversed the effects of huperzine A on TNF‐α production and MAPKs phosphorylation. In conclusion, delayed and chronic administration of huperzine A could protect against 2VO‐induced cognitive impairment, which might be related to its beneficial effects on WML, and the nAChR‐dependent cholinergic anti‐inflammation pathway plays an important role.Keywords
This publication has 63 references indexed in Scilit:
- Acetylcholine beyond neurons: the non‐neuronal cholinergic system in humansBritish Journal of Pharmacology, 2008
- Amoeboid Microglia in the Periventricular White Matter Induce Oligodendrocyte Damage through Expression of Proinflammatory Cytokines via MAP Kinase Signaling Pathway in Hypoxic Neonatal RatsBrain Pathology, 2008
- Pathogenesis of cerebral white matter injury of prematurityArchives of Disease in Childhood - Fetal and Neonatal Edition, 2008
- TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative diseaseJournal of Neuroinflammation, 2008
- Alpha7 nicotinic acetylcholine receptor: A link between inflammation and neurodegenerationNeuroscience & Biobehavioral Reviews, 2008
- The inflammatory response in strokeJournal of Neuroimmunology, 2007
- Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapiesNeuroradiology, 2006
- Cilostazol Protects Against Brain White Matter Damage and Cognitive Impairment in a Rat Model of Chronic Cerebral HypoperfusionStroke, 2006
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- Protective Effect of Cyclosporin A on White Matter Changes in the Rat Brain After Chronic Cerebral HypoperfusionStroke, 1995